Downloadable Slides


Share

Program Content

Activities

  • CDK4_6 Inhibitors in HR+, HER2-Negative Breast Cancer
    Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2024

    Expires: May 29, 2025

  • Inhibiteurs de CDK4/6 cancer du sein HR+/HER2-
    Conversations autour du cancer portant sur l'élargissement du paysage thérapeutique des inhibiteurs de CDK4/6 dans le traitement du cancer du sein HR+/HER2-
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2024

    Expires: July 25, 2025

  • Inibidores de CDK4/6 em câncer de mama HR+/HER2-
    Conversas sobre o câncer: o cenário terapêutico em expansão para inibidores de CDK4/6 em câncer de mama HR-positivo/HER2-negativo
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 19, 2024

    Expires: August 18, 2025

  • Los inhibidores de CDK4/6 en el cáncer de mama RH+/HER2-
    Conversaciones sobre el cáncer de mama RH positivo/HER2 negativo en el panorama terapéutico en expansión de los inhibidores de CDK4/6
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 21, 2024

    Expires: August 20, 2025

Faculty

cover img faculity

Sara A. Hurvitz, MD, FACP

Professor of Medicine
Head, Division of Hematology and Oncology
Department of Medicine, UW Medicine
Senior Vice President
Clinical Research Division
Fred Hutchinson Cancer Center
Seattle, Washington

cover img faculity

Erica L. Mayer, MD, MPH

Director of Breast Cancer Clinical Research
Institute Physician
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Chair, Breast Disease Committee
Sarah Cannon Research Institute
Texas Oncology
Dallas, Texas

Provided by

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation